Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Announces $0.30 Quarterly Dividend

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) declared a quarterly dividend on Tuesday, February 4th,Wall Street Journal reports. Investors of record on Friday, February 14th will be paid a dividend of 0.30 per share by the real estate investment trust on Friday, February 28th. This represents a $1.20 annualized dividend and a dividend yield of 7.18%. The ex-dividend date of this dividend is Friday, February 14th.

Sabra Health Care REIT has raised its dividend by an average of 24.3% per year over the last three years. Sabra Health Care REIT has a payout ratio of 160.0% meaning the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities research analysts expect Sabra Health Care REIT to earn $1.45 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 82.8%.

Sabra Health Care REIT Stock Performance

Shares of NASDAQ SBRA traded down $0.19 during trading on Tuesday, reaching $16.72. 1,941,846 shares of the company traded hands, compared to its average volume of 1,659,170. The stock has a market cap of $3.96 billion, a P/E ratio of 40.78, a PEG ratio of 2.01 and a beta of 1.25. The firm’s fifty day simple moving average is $17.33 and its 200 day simple moving average is $17.62. The company has a current ratio of 4.16, a quick ratio of 4.16 and a debt-to-equity ratio of 0.90. Sabra Health Care REIT has a 12-month low of $12.83 and a 12-month high of $20.03.

Analyst Ratings Changes

Several research firms have commented on SBRA. Scotiabank upped their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “sector perform” rating in a research report on Friday, October 11th. Truist Financial downgraded shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating and lowered their price target for the stock from $18.00 to $17.00 in a report on Friday, January 17th. Citizens Jmp raised shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 7th. Mizuho reissued a “neutral” rating and set a $20.00 target price on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Finally, JMP Securities upgraded Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target for the company in a research note on Tuesday, January 7th. Three analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $18.86.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.